Roche’s Lipoprotein Blood Test Gets Breakthrough Device Designation
Roche announced that its Tina-quant lipoprotein Lp(a) RxDx assay received Breakthrough Device Designation from the FDA.
Read MorePosted by Andy Lundin | May 22, 2024 | Cardiovascular |
Roche announced that its Tina-quant lipoprotein Lp(a) RxDx assay received Breakthrough Device Designation from the FDA.
Read MorePosted by Andy Lundin | May 22, 2024 | Molecular Diagnostics |
Integrated DNA Technologies and Molecular Health entered into a global multi-year agreement to integrate their NGS capabilities.
Read MorePosted by Andy Lundin | May 21, 2024 | Sequencing Systems |
Foundation Medicine launched a tissue-based RNA sequencing test in the U.S. for the detection of cancer-related fusions across 318 genes.
Read MorePosted by Chris Wolski | May 16, 2024 | Diabetes & Metabolic Diseases |
Luxor Scientific and CIMA Sciences have launched OWLiver, a non-invasive blood test to detect all stages of metabolic liver disease.
Read MorePosted by Chris Wolski | May 14, 2024 | Colorectal |
Mainz Biomed N.V. announced results from a clinical study to evaluating integrating its portfolio into its colorectal cancer screening tool.
Read More